EndoStream Medical
Aneurysm Devices
Company Overview
Snapshot
Founded in October 2015 by Danel Mayer and Alon May, EndoStream Medical operates with 11–50 employees. The company was acquired by Kaneka Corporation in January 2025.
Business overview
EndoStream Medical is dedicated to developing safe and effective solutions that significantly improve clinical outcomes for patients suffering from brain aneurysms. The company's aneurysm devices utilize self-conforming scaffolds that adapt to an aneurysm’s unique shape and provide maximal neck metal coverage. EndoStream developed Nautilus, an atraumatic, self-conforming intrasaccular flow diverter maximizing neck coverage and enhancing coil stability, to optimize intrasaccular thrombosis and enable progressive occlusion. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics, serving the global healthcare market.
Strategic signal
EndoStream Medical's acquisition by Kaneka Corporation in January 2025 signals a significant validation of its aneurysm device technology and market potential. This strategic move by a multinational corporation indicates a strong belief in EndoStream's Nautilus device and its ability to improve patient outcomes, potentially accelerating its global reach and further development within the neurovascular treatment landscape.
Log in to access full profile ›Company Intelligence Q&A
- What is EndoStream Medical's primary focus?
- EndoStream Medical focuses on developing safe and effective aneurysm devices, such as the Nautilus, to improve clinical outcomes for patients with brain aneurysms.
- When was EndoStream Medical acquired?
- EndoStream Medical was acquired by Kaneka Corporation in January 2025.
- What is the Nautilus device?
- Nautilus is an atraumatic, self-conforming intrasaccular flow diverter developed by EndoStream Medical to maximize neck coverage and enhance coil stability for optimizing intrasaccular thrombosis and progressive occlusion in aneurysm treatment.
- When did EndoStream Medical enroll its first patient in a trial for the Nautilus Intrasaccular System?
- EndoStream Medical enrolled its first patient in a trial of the Nautilus Intrasaccular System in February 2023.
- Which investors participated in EndoStream Medical's January 2020 funding round?
- In January 2020, EndoStream Medical received funding from.